View Author
patient myeloma bortezomib treatment dexamethasone thalidomide therapy lenalidomide study trial blood regimen response phase agent combination result grade novel agents novel survival transplantation neutropenia outcome melphalan cycle prednisone cancer month induction maintenance group ef ficacy myeloma patients disease oncol celgene relapse cyclophosphamide j clin oncol cell transplantation factor randomized autologou /refractory doxorubicin cytogenetic risk strati fication induction therapy signi consolidation signi ficantly toxicity ficacy response rate /refractory myeloma chemotherapy high-dose effect pegylated liposomal doxorubicin meeting abstr palumbo table number prognostic analysis neuropathy university haematol g-csf leukemia honoraria richardson hematology erasmus mc addition fication department impact
7 Most Recent Publications
|
Plasma cell leukemia: Consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
(Article)
Fernández De Larrea, C. Kyle, R. Kumar, S. Mahindra, A. Comenzo, R.L. Palumbo, A. Mazumber, A. Anderson, K.C. Richardson, P.G. Badros, A.Z. Caers, J. Cavo, M. Durie, B.G.M. Leleu, X. Dimopoulos, M.A. Chim, C.S. Schots, R. Noeul, A. Fantl, D. Mellqvist, U.H. Landgren, O. Chanan-Khan, A. Moreau, P. Ludwig, H. Fonseca, R. Merlini, G. Lahuerta, J.J. Bladé, J. Orlowski, R.Z. Shah, J.J. Usmani, S.M. Vesole, D. Hajek, R. San Miguel, J-F. Sezer, O. Sonneveld, P. |
2013-04-01
|
|
How to manage neutropenia in multiple myeloma
(Article)
Palumbo, A. Bladé, J. Spencer, A. Sonneveld, P. San Miguel, J-F. Boccadoro, M. Palladino, C. Davies, F. Dimopoulos, M.A. Dmoszynska, A. Einsele, H. Moreau, P. Sezer, O. |
2012-02-01
|
|
Personalized therapy in multiple myeloma according to patient age and vulnerability: A report of the European Myeloma Network (EMN)
(Article)
Palumbo, A. Bringhen, S. Zweegman, S. Terpos, E. Davies, F. Driessen, C. Gimsing, P. Gramatzki, M. Hajek, R. Johnsen, H.E. Da Costa, F.L. Sezer, O. Ludwig, H. Spencer, A. Beksaç, M. Morgan, G. Einsele, H. San Miguel, J. Sonneveld, P. Dimopoulos, M.A. Bladé, J. Mateos, M.V. Rosiñol, L. Boccadoro, M. Cavo, M. Lokhorst, H.M. |
2011-10-27
|
|
International myeloma working group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation
(Article)
Cavo, M. Rajkumar, S.V. Sonneveld, P. Boccadoro, M. Anderson, K.C. Richardson, P.G. Bensinger, W. Johnsen, H.E. Kroeger, N. Gahrton, G. Bergsagel, P.L. Vesole, D.H. Palumbo, A. Einsele, H. Jagannath, S. Niesvizky, R. Durie, B.G.M. Miguel, J.S. Lonial, S. Moreau, P. Orlowski, R.Z. Bladé, J. Sezer, O. Ludwig, H. Dimopoulos, M.A. Attal, M. |
2011-06-09
|
|
Treatment of relapsed and refractory multiple myeloma in the era of novel agents
(Article)
Donk, N.W.C.J. van de Lokhorst, H.M. Goldschmidt, H. Sonneveld, P. Johnsen, H.E. Bladé, J. San-Miguel, J-F. Palumbo, A. Dimopoulos, M.A. Cavo, M. Morgan, G. Einsele, H. Kropff, M. Schey, S. Avet-Loiseau, H. Ludwig, H. |
2011-06-01
|
|
Multiple myeloma treatment strategies with novel agents in 2011: A European perspective
(Article)
Ludwig, H. Beksaç, M. Goldschmidt, H. Harousseau, J-L. Hess, U. Kropff, M. Da Costa, F.L. Louw, V. Magen-Nativ, H. Mendeleeva, L. Nahi, H. Plesner, T. Bladé, J. San Miguel, J. Sonneveld, P. Udvardy, M. Sondergeld, P. Palumbo, A. Cavenagh, J. Cavo, M. Delforge, M. Dimopoulos, M.A. Drach, J. Einsele, H. Facon, T. |
2011-05-06
|
|
Consensus recommendations for risk stratification in multiple myeloma: Report of the International Myeloma Workshop Consensus Panel 2
(Article)
Munshi, N.C. Anderson, K.C. Jagannath, S. Hajek, R. Sezer, O. Kyle, R. Sonneveld, P. Cavo, M. Rajkumar, S.V. San-Miguel, J-F. Crowley, J. Avet-Loiseau, H. Bergsagel, P.L. Shaughnessy, J. Palumbo, A. Durie, B.G.M. Fonseca, R. Stewart, A.K. Harousseau, J-L. Dimopoulos, M.A. |
2011-05-05
|
